BersonS.A., YalowR.S., AurbachG.D., PottsJ.T.Jr.: Immunoassay of bovine and human parathyroid hormone.Proc. Nat. Acad. Sci., U.S., 49, 613, 1963.
2.
ArnaudC.D., GoldsmithR.S., BordierP., SizemoreG.W.: Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in man.Amer. J. Med., 56, 785, 1974.
3.
YalowR.S.: Significance of the heterogeneity of parathyroid hormone. In: Endocrinology of Calcium Metabolism, CoppD.H., and TalmageR.V., Eds., Exerpta Medica, Amsterdam, 1977, pp 308–312.
4.
FlueckJ.A., Di BellaF.P., EdisA.J., KehrwaldJ.M., ArnaudC.D.: Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.J. Clin. Invest., 60, 1367, 1977.
5.
BersonS.A., YalowR.S.: Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma.Science, 154, 907, 1966.
6.
ArnaudC.D., TsaoH.S., LittledikeT.: Radioimmunoassay of human parathyroid hormone in serum.J. Clin. Invest., 50, 21, 1971.
7.
ReissE., CanterburyJ.M., EgdahlR.H.: Experience with a radioimmunoassay of parathyroid hormone in human sera.Trans. Assoc. Amer. Physicians, 81, 104, 1968.
8.
ArnaudC.D.: Hyperparathyroidism and renal failure.Kidney Int., 4, 89, 1973.
9.
GoldsmithR.S., JohnsonW.J., ArnaudC.D.: The hyperparathyroidism of renal failure: pathophysiology and treatment.Clin. Endocrinol. Metab., 3, 305, 1974.
10.
BrickerN.S.: On the pathogenesis of the uremic state: an exposition of the «trade-off hypothesis».New Eng. J. Med., 286, 1093, 1972.
MartinK.J., HruskaK.A., FreitagJ.J., KlahrS., SlatopolskyE.: The peripheral metabolism of parathyroid hormone.N. Engl. J. Med., 301, 1092, 1979.
13.
ReckerR., SchoenfeldP., LetteriJ., SlatopolskyE., GoldsmithR., BrickmanA.: The efficacy of calcifediol in renal osteodystrophy.Arch. Int. Med., 138, 857, 1978.
14.
FreitagJ., MartinK.J., HruskaK.A., AndersonC., ConradesM., LadensonJ., KlahrS., SlatopolskyE.: Impaired parathyroid hormone metabolism in patients with chronic renal failure.N. Engl. J. Med., 298, 29, 1978.
15.
SilvermanR., YalowR.S.: Heterogeneity of parathyroid hormone: clinical and physiologic implications.J. Clin. Invest., 52, 1958, 1973.
16.
HawkerC.D., Di BellaF.P.: Parathyroid hormone in chronic renal failure: studies with two different parathyroid hormone radioimmunoassays.Contrib. Nephrol., 20, 21, 1980.
17.
FrostH.M., GriffithD.L., JeeW.S.S., KimmelD., McCandlisR.P., TeitelbaumS.L.: Histomorphometric changes in trabecular bone of renal failure patients treated with calcifediol.Metab. Bone Dis. Rel. Res.2, 285, 1981.
18.
MartinK., HruskaK.A., GreenwaltA., KlahrS., SlatopolskyE.: Selective uptake of intact parathyroid hormone by the liver: differences between hepatic and renal uptake.J. Clin. Invest.58, 781, 1976.
19.
JacobA.I., LanierD.Jr., CanterburyJ., BourgoignieJ.J.: Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.N. Engl. J. Med., 302, 671, 1980.
20.
CaroJ.F., BesarabA., BurkeJ.F., GlennonJ.A.: A possible role for propranolol in the treatment of renal osteodystrophy.Lancet, 2, 451, 1978.